NEC OncoImmunity Acquires VAXIMM's Neoantigen Vaccine Development Assets
08.03.2022 NEC OncoImmunity Acquires VAXIMM's Neoantigen Vaccine Development Assets | Aquisition | NEC Corporation
Source: dgap.de
Stay updated with breaking news from Ec Oncoimmunity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
08.03.2022 NEC OncoImmunity Acquires VAXIMM's Neoantigen Vaccine Development Assets | Aquisition | NEC Corporation